Search results
Results From The WOW.Com Content Network
In an earlier trial, retatrutide helped people lose, on average, about 24% of their body weight, the equivalent of about 58 pounds — greater weight loss than any other drug on the market. New ...
Novo plans to begin a new trial of CagriSema in the first half of 2025 which will be longer than the original 68-week study because the data suggested additional weight loss could be achieved with ...
(Reuters) - The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business currently dominated by Novo Nordisk and Eli Lilly, according to ...
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.
And based on the data so far, amycretin looks even more impressive than Wegovy and Eli Lilly's Zepbound, the two top-selling weight loss drugs. In a 72-week study, Zepbound's mean weight loss was ...
"I consider the drugs available on the market today as the first generation of weight-loss drugs," the senior study author said. "Now we have developed a new type of weight-loss drug."
The weight loss drugs semaglutide may help individuals with alcohol addiction. [125] The 2024 research analyzed the records of nearly 228,000 people in Sweden from 2006 until 2023 and noticed that those using semaglutide or liraglutide were significantly less likely to face alcohol-related hospitalizations. [126]
The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months.
Ads
related to: new weight loss drugs on the market